Hino, Japan

Kenji Hoshina



Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 67(Granted Patents)


Location History:

  • Yokohama, JP (1983)
  • Hino, JP (1983 - 1997)

Company Filing History:


Years Active: 1983-1997

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kenji Hoshina: Innovator in Pyrrolopyrimidine Derivatives

Introduction

Kenji Hoshina, an accomplished inventor based in Hino, Japan, has made significant contributions to the field of pharmaceutical chemistry with a focus on pyrrolopyrimidine derivatives. With a total of four patents to his name, Hoshina’s work is characterized by innovative processes and formulations that advance therapeutic options.

Latest Patents

Hoshina’s latest patents include groundbreaking work on pyrrolo[2,3-d]pyrimidine derivatives. This includes a detailed process for producing these compounds and the formulation of a pyrrolo[2,3-d]pyrimidine derivative that possesses a general formula allowing the definition of various substituents (R¹, R², R³, R⁴, R⁵, Y, and Z). These derivates can form pharmaceutically acceptable acid addition salts and are aimed at improving pharmaceutical preparations. Additionally, Hoshina has worked on a fused pyrimidine derivative and its preparation method, further demonstrating his expertise in this crucial area of drug design.

Career Highlights

Kenji Hoshina plays a vital role at Teijin Limited, where his innovative research and development efforts continue to influence the pharmaceutical industry. With his keen insight and creative approach, Hoshina stands out amongst his peers, having contributed significantly to advancements in medicinal chemistry.

Collaborations

Throughout his career, Hoshina has collaborated with talented colleagues including Yasuji Sakuma and Masaichi Hasegawa. Their combined efforts and intellectual synergies foster a productive environment that leads to the successful development of novel pharmaceutical compounds.

Conclusion

Kenji Hoshina exemplifies the innovative spirit of modern invention, particularly in the realm of pharmaceuticals. His significant contributions to the development of pyrrolopyrimidine derivatives reflect his commitment to advancing healthcare through science and innovation. As he continues his journey with Teijin Limited, the impact of his work will likely resonate within the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…